We have developed an application that integrate an in-house genetic algorithm for an interactive and automatic data processing to support early therapeutic and clinical decision making in rheumatoid arthritis. Through data collection protocols, the healthcare professionals involved store patient biomarkers for later evaluation. With the highest quality and accessibility standards, we have developed a reliable and secure platform for which we will evaluate and demonstrate its operation and final clinical safety, prior to its commercialization as a medical device. At present, this digital prognostic tool can be used for research.